Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

GSK plc DRC (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GSK plc DRC's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
35.13 -0.36    -1.01%
02/02 - Closed. Currency in USD ( Disclaimer )
After Hours
35.28
+0.15
+0.43%
0:52:37 - Real-time Data
  • Volume: 5,443,733
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 34.87 - 35.61
Type:  Equity
Market:  United States
GSK plc DRC 35.13 -0.36 -1.01%

GSK Financial Summary

 
See below for an overview of the GlaxoSmithKline financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

GSK plc reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was GBP 7,829 million compared to GBP 6,627 million a year ago. Net income was GBP 10,315 million compared to GBP 1,168 million a year ago. Basic earnings per share from continuing operations was GBP 0.188 compared to GBP 0.219 a year ago. Diluted earnings per share from continuing operations was GBP 0.186 compared to GBP 0.216 a year ago. Basic earnings per share was GBP 2.559 compared to GBP 0.292 a year ago. Diluted earnings per share was GBP 2.523 compared to GBP 0.288 a year ago.For the nine months, sales was GBP 21,948 million compared to GBP 17,620 million a year ago. Net income was GBP 12,955 million compared to GBP 3,636 million a year ago. Basic earnings per share from continuing operations was GBP 0.736 compared to GBP 0.722 a year ago. Diluted earnings per share from continuing operations was GBP 0.725 compared to GBP 0.714 a year ago. Basic earnings per share was GBP 3.22 compared to GBP 0.908 a year ago. Diluted earnings per share was GBP 3.173 compared to GBP 0.898 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GSK Income Statement

Gross margin TTM 67.42%
Operating margin TTM 24.19%
Net Profit margin TTM 35.65%
Return on Investment TTM 14.78%
 Total Revenue  Net Income
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Revenue 7829 6929 7190
Gross Profit 5443 4784 4500
Operating Income 2361 1709 1708
Net Income 10315 838 1802

GSK Balance Sheet

Quick Ratio MRQ 0.65
Current Ratio MRQ 0.91
LT Debt to Equity MRQ 160.74%
Total Debt to Equity MRQ 198.03%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Assets 60313 89045 89689 79103
Total Liabilities 51597 66405 67057 57761
Total Equity 8716 22640 22632 21342

GSK Cash Flow Statement

Cash Flow/Share TTM 1.82
Revenue/Share TTM 7.22
Operating Cash Flow  6.30%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1321 2542
Cash From Investing Activities -4094 -3593
Cash From Financing Activities -1326 7973
Net Change in Cash -4076 6934
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK movie forward. Thanks you
Faruk Mia
Faruk Mia Apr 27, 2021 7:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
হাই
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email